Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000633092 | SCV000754304 | benign | Spastic paraplegia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001109204 | SCV001266515 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Athena Diagnostics | RCV001288369 | SCV001475433 | benign | not specified | 2020-02-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001558026 | SCV001779893 | likely benign | not provided | 2020-01-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001109204 | SCV002026581 | likely benign | Charlevoix-Saguenay spastic ataxia | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001849010 | SCV002104954 | likely benign | Hereditary spastic paraplegia | 2017-06-23 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001109204 | SCV001459479 | benign | Charlevoix-Saguenay spastic ataxia | 2020-09-16 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001288369 | SCV001956335 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001558026 | SCV001965437 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003935764 | SCV004756584 | benign | SACS-related disorder | 2019-08-07 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |